Why is Divis Lab share increasing?
Table of Contents
“The growth was driven primarily by custom synthesis business while generics declined year-on-year (YoY). The strong positioning of Divis will help in monetising the growth opportunity in API and CRAMS space given its stellar execution track record, recent capex of Rs 25billion and being one of the preferred suppliers.
Will Divi`s Laboratories stock price grow / rise / go up? Yes. The Divis Laboratories Ltd stock price can go up from 4511.100 INR to 6002.130 INR in one year.
Is Divis Lab Large Cap?
This is the ranking of a company within its sector based on MCap or Market capitalization. Higher the market capitalization of a company, higher the rank it is assigned. This represents the 52 week high and low price of the security….Key Metrics.
| 1 Month | 1.54 |
|---|---|
| 6 Months | 0.77 |
| 1 Year | 1.01 |
| 3 Years | 1.06 |
What are the products of Divis Lab?
COMMERCIAL PRODUCTS
| S.No | Product | Therapeutic Category |
|---|---|---|
| 1. | Capecitabine | Antineoplastic |
| 2. | Carbidopa | Antiparkinson |
| 3. | Diltiazem HCl | Anti Hypersensitive |
| 4. | Dextromethorphan Base | Anti Tussive, Analgesic |
Is Polycab debt free company?
Succinctly put, Polycab India boasts net cash, so it’s fair to say it does not have a heavy debt load! This free cash flow puts the company in a good position to pay down debt, when appropriate.
Is Divis Lab a good company?
Divis laboratories is a good company to work with. You will get wide range of exposure in this company. According to safety , E. H. S, quality , GMP norms it would stands one of the greatest companies in india.
Is Divis Lab an Indian company?
Divi’s Laboratories Limited is an Indian Pharmaceuticals company and producer of active pharmaceutical ingredients (APIs) and intermediates headquartered in Hyderabad, Telangana, India.